| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/1995 | CA2118193A1 Triazine derivatives, production and use thereof |
| 04/16/1995 | CA2118188A1 Antihistaminic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/1995 | CA2118097A1 Methods for inhibiting angiogenesis and angiogenic diseases |
| 04/16/1995 | CA2118096A1 Methods for treating resistant neoplasms |
| 04/16/1995 | CA2118095A1 Methods for inhibiting smooth muscle cell proliferation and restinosis |
| 04/16/1995 | CA2118094A1 Methods for inhibiting cartilage degradation |
| 04/16/1995 | CA2118093A1 Methods for the treatment of peri-menopausal syndrome |
| 04/16/1995 | CA2118092A1 Methods of inhibiting endometriosis |
| 04/16/1995 | CA2118090A1 Methods of inhibiting uterine fibrosis |
| 04/16/1995 | CA2117854A1 Methods for inhibiting bone loss |
| 04/16/1995 | CA2117853A1 Methods for lowering serum cholesterol |
| 04/15/1995 | CA2118098A1 Stable liquid preparation of complex vitamin for internal use |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | WO1995009863A1 Process and antiparasitic intermediates for doramectin |
| 04/13/1995 | WO1995009862A1 Water-soluble retinoids |
| 04/13/1995 | WO1995009857A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/13/1995 | WO1995009856A1 Boronated metalloporphyrins and therapeutic methods |
| 04/13/1995 | WO1995009853A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009852A1 Further pyrimidine derivatives and their preparation |
| 04/13/1995 | WO1995009851A1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009848A2 Polyazacycloalkanes as dichelants |
| 04/13/1995 | WO1995009847A1 Pyrimidineamine derivatives and processes for the preparation thereof |
| 04/13/1995 | WO1995009845A1 Pyrimidinyl-glutamic acid derivatives |
| 04/13/1995 | WO1995009843A1 Hiv protease inhibitors |
| 04/13/1995 | WO1995009842A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/13/1995 | WO1995009838A1 INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
| 04/13/1995 | WO1995009835A1 Novel phenylethyl and phenylpropylamines |
| 04/13/1995 | WO1995009831A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009652A1 Treatment of autoimmune and inflammatory disorders |
| 04/13/1995 | WO1995009638A1 Improvements relating to antibacterial compositions |
| 04/13/1995 | WO1995009637A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/13/1995 | WO1995009636A1 Method of inducing vasorelaxation to treat pulmonary hypertension |
| 04/13/1995 | WO1995009635A1 Composition for the treatment or prevention of herpes |
| 04/13/1995 | WO1995009632A1 Use of penciclorin for the treatment of post-therapeutic neuralgia |
| 04/13/1995 | WO1995009628A1 Therapeutic application of perhydroisoindole derivatives as an anti-emetic |
| 04/13/1995 | WO1995009627A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
| 04/13/1995 | WO1995009625A1 Use of amiodarone for the treatment of heart failure |
| 04/13/1995 | WO1995009624A1 Compounds, compositions and treatment of allergies and inflammation |
| 04/13/1995 | WO1995009622A1 Polyunsaturated fatty acids and uses thereof |
| 04/13/1995 | WO1995009621A1 Pharmaceutical compositions containing nitric oxide synthase inhibitors and anti-cancer agents |
| 04/13/1995 | WO1995009619A2 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 04/13/1995 | WO1995009618A1 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor |
| 04/13/1995 | WO1995009614A1 Pharmaceutical composition |
| 04/13/1995 | WO1995009613A1 Controlled release microspheres |
| 04/13/1995 | WO1995009612A1 Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
| 04/13/1995 | WO1995009609A1 New emulsion formulation |
| 04/13/1995 | WO1995009607A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | WO1995009606A1 Viscoelastic compositions of fluorinated organic compounds |
| 04/13/1995 | WO1995009601A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 04/13/1995 | WO1995009590A1 Absorption enhancers for topical pharmaceutical formulations |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | WO1995005167A3 Treatment of adverse effects associated with administration of extracellular hemoglobin |
| 04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 04/13/1995 | DE4341139C1 Dimethicone for the treatment of aphthae |
| 04/13/1995 | DE4042492C2 Use of 4,5-di:substituted imidazole cpds. |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2173321A1 Viscoelastic compositions of fluorinated organic compounds |
| 04/13/1995 | CA2173234A1 Pyrimidinyl-glutamic acid derivatives |
| 04/13/1995 | CA2173111A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 04/13/1995 | CA2173109A1 Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use |
| 04/13/1995 | CA2172738A1 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor |
| 04/13/1995 | CA2172735A1 Polyazacycloalkanes as dichelants |
| 04/13/1995 | CA2172415A1 Boronated metalloporphyrins and therapeutic methods |
| 04/13/1995 | CA2172143A1 New emulsion formulation |
| 04/13/1995 | CA2172124A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 04/13/1995 | CA2171465A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2169084A1 Improvements relating to antibacterial compositions |
| 04/13/1995 | CA2167413A1 Pharmaceutical composition |
| 04/13/1995 | CA2150005A1 Novel phenylethyl and phenylpropylamines |
| 04/13/1995 | CA2148931A1 Pyrimidineamine derivatives and processes for the preparation thereof |
| 04/13/1995 | CA2148477A1 Further pyrimidine derivatives and their preparation |
| 04/13/1995 | CA2148361A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/13/1995 | CA2133815A1 Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof |
| 04/13/1995 | CA2117821A1 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them |
| 04/12/1995 | EP0647649A1 Novel crystal of monohydrate of heterocyclic bis(phosphonic acid) derivative |
| 04/12/1995 | EP0647644A1 Antibacterial pyrido 1,2,3-d,e 1,3,4 benzoxacin derivatives |
| 04/12/1995 | EP0647642A1 1-Azabicyclo(3.3.0)octane derivatives and their use |
| 04/12/1995 | EP0647641A1 Substituted heterocyclylisoquinolinium salts and compositions and methods of usethereof |
| 04/12/1995 | EP0647640A1 Process for the preparation of pilocarpine derivatives |
| 04/12/1995 | EP0647636A1 Benzothiazole compound, process for producing the same, and use thereof |
| 04/12/1995 | EP0647629A1 Neurotensin active substituted 1-naphthylpyrazole-3-carboxamides, their preparation and pharmaceutical compositions containing them |
| 04/12/1995 | EP0647627A1 1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridines as angiotensin II antagonists |
| 04/12/1995 | EP0647621A1 Aryl and heterocylic cyanoguanidine derivatives |
| 04/12/1995 | EP0647617A1 Ceramides, process for their preparation and their cosmetic uses |
| 04/12/1995 | EP0647616A1 Zinc tranexamate compound |
| 04/12/1995 | EP0647451A1 Inclusion complex of beta-cyclodextrin with diclofenac |
| 04/12/1995 | EP0647450A1 Improved prodrugs for enzyme mediated activation |
| 04/12/1995 | EP0647448A1 Orally administrable opioid formulations having extended duration of effect |
| 04/12/1995 | EP0647447A1 Carbostyril derivatives as phosphodiesterase inhibitors |
| 04/12/1995 | EP0647446A1 Novel medicinal use of dihydropyridine derivative |
| 04/12/1995 | EP0647445A1 Composition for prophylaxis and treatment of myopia |
| 04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647258A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 04/12/1995 | EP0647235A1 Process for steroidal peracyl glycosides. |
| 04/12/1995 | EP0647234A1 Steroidal glycosides for treating hypercholesterolemia |